SCHEMBL2986387

SCHEMBL2986387

Cc1ccn2c(NCc3cccc(Cl)c3)c(CO)nc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLAU P00749 1/20 0.50
MAPT P10636 4/20 0.47
ALDH1A1 P00352 4/20 0.47
KDM4E B2RXH2 3/20 0.47
GAA P10253 3/20 0.47
RAB9A P51151 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
NPC1 O15118 1/20 0.47
POLB P06746 1/20 0.47
NR1H4 Q96RI1 3/20 0.45
PDE2A O00408 2/20 0.43
HPGD P15428 2/20 0.42
KCNN3 Q9UGI6 2/20 0.41
MAPK1 P28482 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
BRD4 O60885 1/20 0.41
CREBBP Q92793 1/20 0.41
ATM Q13315 1/20 0.40
MEN1 O00255 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2984337 0.81 MAPT (0.51) MAPTALDH1A1KDM4EGAARAB9A
SCHEMBL2986401 0.80 MAPT (0.60) MAPTALDH1A1KDM4EGAARAB9A
SCHEMBL2992215 0.79 ALDH1A1 (0.51) MAPTALDH1A1KDM4EGAARAB9A
SCHEMBL2989095 0.78 MAPT (0.48) MAPTALDH1A1KDM4EGAARAB9A
SCHEMBL2989780 0.78 MAPT (0.51) MAPTALDH1A1KDM4EGAARAB9A
SCHEMBL2986422 0.76 NR1H4 (0.47) MAPTALDH1A1KDM4EGAARAB9A
SCHEMBL2978006 0.74 MAPT (0.44) MAPTALDH1A1KDM4EGAARAB9A
SCHEMBL19723587 0.73 KMT2A (0.52) MAPTALDH1A1KDM4EGAARAB9A
SCHEMBL2989998 0.73 NR1H4 (0.66) PLAUMAPTALDH1A1KDM4EGAA
SCHEMBL2987088 0.72 SIRT1 (0.51) PLAUMAPTALDH1A1KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100173930-A1 Certain Chemical Entities, Compositions and Methods CYTOKINETICS, INC. 2010-07-08 US claimed
WO-2008016648-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS CYTOKINETICS, INCORPORATED (US) 2008-02-07 WO claimed
US-20100173930-A1 Certain Chemical Entities, Compositions and Methods CYTOKINETICS, INC. 2010-07-08 US disclosed
WO-2008016648-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS CYTOKINETICS, INCORPORATED (US) 2008-02-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100173930-A1 Certain Chemical Entities, Compositions and Methods TNNC1, TNNI3, TNNT2 PLAU 2493/4885MAPT 218/4885ALDH1A1 3165/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.